Literature DB >> 6303322

Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells.

E N Fish, K Banerjee, N Stebbing.   

Abstract

The antigrowth effects of 5 different cloned human leukocyte IFN subtypes (IFN-alpha A, B, C, D, F) and 2 molecular hybrids between them (IFN-alpha AD(Bg1II) and IFN-alpha DA(Bg1II)) were examined on 6 different human cell lines. The results indicate that the interferons sort into two distinct groups: IFN-alpha B, C and F showed comparable antiproliferative activity which was greater than that of IFN-alpha A, D, AD(Bg1II) and DA(Bg1II). The interferons could also be assigned to one of two groups on the basis of their antiviral activity. IFN-alpha A, D and AD(Bg1II) were observed to be more protective than IFN-alpha B, C and F against HSV-2 and EMCV infections, i.e. the relative antiviral efficacies of the cloned IFN subtypes were the reverse of their antiproliferative activities.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303322     DOI: 10.1016/0006-291x(83)91498-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Treatment with human recombinant leukocyte interferons inhibits in vitro invasive ability of human lung carcinoma cells.

Authors:  T J Ravine; N Ledinko
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

2.  Comparison of antiviral activities of cloned and native human interferons against herpes simplex virus types 1 and 2 and human cytomegalovirus.

Authors:  L E Rasmussen; P T Chen; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

3.  Natural human interferon-alpha 2 is O-glycosylated.

Authors:  G R Adolf; I Kalsner; H Ahorn; I Maurer-Fogy; K Cantell
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

4.  Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters.

Authors:  E N Fish; K Banerjee; H L Levine; N Stebbing
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

5.  The role of consensus interferon in the current treatment of chronic hepatitis C viral infection.

Authors:  Eleanor N Fish; Stephen A Harrison; Tarek Hassanein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-09

6.  PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.

Authors:  Jose Ramon; Vivian Saez; Reynier Baez; Raymersy Aldana; Eugenio Hardy
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

7.  Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon.

Authors:  G Scotto; M Grimaldi
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

8.  A phase I trial of intrapleural recombinant human interferon alpha (rHuIFN alpha 2b) in patients with malignant pleural effusions.

Authors:  A Bhatia; T W Rice; D McLain; P Herzog; G T Budd; S Murthy; T J Kirby; R M Bukowski
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.

Authors:  Carolina Scagnolari; Milvia Casato; Francesca Bellomi; Francesca De Pisa; Ombretta Turriziani; Rossella Coviello; Maria Rosaria Pirro; Ferdinando Dianzani; Guido Antonelli
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Transcriptional regulation of interferon-responsive genes is closely linked to interferon receptor occupancy.

Authors:  G Hannigan; B R Williams
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.